FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Has signed a series of Japanese and European sales agreements for its biosimilar and oral GLP-1 generic. Also seen: Late clinical · capacity

  • Disclosed an exclusive Japanese supply and sales agreement for its aflibercept biosimilar. Source
  • Disclosed a licensing agreement for its oral GLP-1 generic covering 11 European countries. Source

Roles often seen at this stageBD & licensing · Regulatory affairs · Manufacturing & MSAT

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Sam Chun Dang Pharm

A pharmaceutical company selling prescription drugs including ophthalmic products, commercialising an aflibercept biosimilar and an oral GLP-1 generic with overseas partners.

SCD411 (aflibercept biosimilar)

Stage unconfirmed

Aflibercept biosimilar for macular degeneration, with exclusive supply agreements in Japan and Europe.

Oral semaglutide generic

Stage unconfirmed

Oral semaglutide generic licensed for 11 European countries.

Announced

Signed an exclusive Japanese supply and sales agreement for its aflibercept biosimilar with a new partner.

Announced

Disclosed a licensing agreement for its oral GLP-1 generic covering 11 European countries.

Official role guide

Sam Chun Dang Pharm careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 삼천당제약, '아일리아 시밀러' 日 DSE와 독점 판매 계약 ↗데일리한국 · Published 2026-11-02 · Sources checked 2026-11-15 · Original unavailable
  2. 삼천당제약, 경구용 GLP-1 유럽 11개국 라이센스 계약 ↗히트뉴스 · Published 2026-02-26 · Sources checked 2026-11-15 · Original unavailable